This article is part of the supplement: 35te Tagung der Pathologen am Oberrhein/35th Meeting of Pathologists of the Upper Rhine Region (PATOR)

Oral presentation

EGFR-gene analysis on cytological specimens of non-small-cell lung cancers

S Savic, B Grilli, A Rufle, M Bihl, A Barascud, M Herzog, C Tapia, L Terracciano, G Feichter and L Bubendorf

Institute for Pathology, University Hospital Basel, Switzerland

corresponding author email

from 35te Tagung der Pathologen am Oberrhein/35th Meeting of Pathologists of the Upper Rhine Region (PATOR)
The Institute of Pathology, University Hospital Freiburg, Germany. 1 July 2006

Diagnostic Pathology 2007, 2(Suppl 1):S15doi:10.1186/1746-1596-2-S1-S15

Published:	14 March 2007

First paragraph (this article has no abstract)

The diagnosis of lung cancer is often based on cytology alone. The relative paucity of tumor cells in these specimens is a challenge for the analysis of epidermal growth factor receptor (EGFR) gene mutation and EGFR gene copy number to select for treatment with EGFR-tyrosine kinase inhibitors. Here, we tested whether such EGFR gene analyses are feasible on cytological specimens of non-small-cell lung cancers (NSCLC).